CVE-2023-52076

Public Exploit
Remote Code Execution Vulnerability in Atril's EPUB ebook parsing

Description

Atril Document Viewer is the default document reader of the MATE desktop environment for Linux. A path traversal and arbitrary file write vulnerability exists in versions of Atril prior to 1.26.2. This vulnerability is capable of writing arbitrary files anywhere on the filesystem to which the user opening a crafted document has access. The only limitation is that this vulnerability cannot be exploited to overwrite existing files, but that doesn't stop an attacker from achieving Remote Command Execution on the target system. Version 1.26.2 of Atril contains a patch for this vulnerability.

Category

8.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 6.55% Top 10%
Vendor Advisory github.com
Affected: mate-desktop atril
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-52076?
CVE-2023-52076 has been scored as a high severity vulnerability.
How to fix CVE-2023-52076?
To fix CVE-2023-52076, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-52076 being actively exploited in the wild?
It is possible that CVE-2023-52076 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~7% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-52076?
CVE-2023-52076 affects mate-desktop atril.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.